Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy

被引:25
|
作者
White, Evan C. [1 ]
Murphy, James D. [1 ]
Chang, Daniel T. [1 ]
Koong, Albert C. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford Canc Inst, Stanford, CA 94305 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2015年 / 38卷 / 06期
关键词
inflammatory bowel disease; toxicity; intensity-modulated radiation therapy (IMRT); RADIOTHERAPY; CANCER; SURGERY; HISTORY; TRIAL; RISK;
D O I
10.1097/COC.0000000000000010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective:To determine the short-term and long-term toxicity of abdominal and pelvic radiation therapy in a cohort of patients with inflammatory bowel disease (IBD). We hypothesize that with newer techniques, such as intensity-modulated radiation therapy (IMRT) and 3-dimensional conformal radiotherapy (3D-CRT), patients with IBD can safely undergo abdominal and pelvic radiation, with low risk for major acute or late toxicity.Materials and Methods:Nineteen consecutive patients with IBD (14 with ulcerative colitis, 5 with Crohn disease) who were treated with abdominal or pelvic external beam radiation therapy at Stanford University from 1997 to 2011 were identified. Fourteen patients were treated with IMRT and 5 were treated with 3D-CRT. Treated sites included prostate (n=8), gastric/esophageal (n=5), rectal/anal (n=3), and liver (n=3) tumors. Charts were reviewed and toxicity was graded according to the Common Terminology Criteria for Acute Events version 4.0. Median follow-up was 32.5 months. Fisher exact test was used to determine if any clinical and/or treatment factors were associated with toxicity outcomes.Results:Acute grade 3 toxicity occurred in 2 patients (11%). Late grade 3 toxicity occurred in 1 patient (6%). Acute grade 2 toxicity occurred in 28% of patients treated with IMRT versus 100% of patients treated with 3D-CRT (P=0.01). Acute grade 2 gastrointestinal toxicity was lower in patients treated with IMRT versus 3D-CRT (14% vs. 100%, respectively, P=0.002). Late grade 2 toxicity occurred in 21% of patients. Higher total dose (Gy) and biologically effective dose (Gy) were associated with increased rates of late grade 2 toxicity (P=0.02 and 0.03, respectively).Conclusions:These data suggest that select patients with IBD can safely undergo abdominal and pelvic radiation therapy. The use of IMRT was associated with decreased acute toxicity. Acute and late severe toxicity rates were low in this patient population with the use of modern radiation techniques.
引用
收藏
页码:564 / 569
页数:6
相关论文
共 50 条
  • [1] Safety of Pelvic and Abdominal Radiation Therapy for Patients With Inflammatory Bowel Disease: A Dosimetric Analysis of Acute Bowel Toxicity
    Hall, Jennifer C.
    Hall, Abbie K.
    Lozko, Yuliia
    Hui, Caressa
    Baniel, Claire C.
    Jackson, Scott
    Vitzthum, Lucas K.
    Chang, Daniel T.
    Rahimy, Elham
    Pollom, Erqi L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (02): : 442 - 451
  • [2] Radiation therapy in patients with inflammatory bowel disease. A review
    Jmour, Omar
    Pellat, Anna
    Colson-Durand, Laurianne
    Nhu Hanh To
    Latorzeff, Igor
    Sargos, Paul
    Sobhani, Iradj
    Belkacemi, Yazid
    BULLETIN DU CANCER, 2018, 105 (05) : 517 - 522
  • [3] Inflammatory bowel diseases activity in patients undergoing pelvic radiation therapy
    Annede, Pierre
    Seisen, Thomas
    Klotz, Caroline
    Mazeron, Renaud
    Maroun, Pierre
    Petit, Claire
    Deutsch, Eric
    Bossi, Alberto
    Haie-Meder, Christine
    Chargari, Cyrus
    Blanchard, Pierre
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (01) : 173 - 179
  • [4] A Matched Case-Control Analysis of Clinical Outcomes for Patients With Inflammatory Bowel Disease and Rectal Cancer Treated With Pelvic Radiation Therapy
    Mudgway, Ross
    Bryant, Alex K.
    Heide, Elena S.
    Riviere, Paul
    O'Hare, Connor
    Rose, Brent S.
    Murphy, James D.
    Simpson, Daniel R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (05): : 994 - 1004
  • [5] Acute toxicity and surgical complications after preoperative (chemo) radiation therapy for rectal cancer in patients with inflammatory bowel disease
    Bosch, Steven L.
    van Rooijen, Stefan J.
    Bokketink, Guus M. J.
    Braam, Hidde J. W.
    Derikx, Lauranne A. A. P.
    Poortmans, Philip
    Marijnen, Corrie A. M.
    Nagtegaal, Iris D.
    de Wilt, Johannes H. W.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 (01) : 147 - 153
  • [6] Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy
    Jansen, Fenna M.
    Smits, Lisa J. T.
    Thomas, Pepijn W. A.
    de Jong, Dirk J.
    Kreijne, Joany E.
    van Dop, Willemijn A.
    den Broeder, Nathan
    Hoentjen, Frank
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (07) : 2936 - 2945
  • [7] Toxicity after 125I prostate brachytherapy in patients with inflammatory bowel disease
    Pai, Howard H.
    Keyes, Mira
    Morris, W. James
    Christie, Jennifer
    BRACHYTHERAPY, 2013, 12 (02) : 126 - 133
  • [8] Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate
    Prebble, Amber R.
    Weishaar, Kristen M.
    Thamm, Douglas H.
    Leary, Del
    LaRue, Susan M.
    Martin, Tiffany
    Boss, Mary-Keara
    VETERINARY AND COMPARATIVE ONCOLOGY, 2022, 20 (01) : 142 - 153
  • [9] Acute and Late Bowel Toxicity in Radiotherapy Patients with Inflammatory Bowel Disease: A Systematic Review
    Tromp, D.
    Christie, D. R. H.
    CLINICAL ONCOLOGY, 2015, 27 (09) : 536 - 541
  • [10] Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: Risks and benefits
    Chang, Bianca W.
    Kumar, Aryavarta M. S.
    Koyfman, Shlomo A.
    Kalady, Matthew
    Lavery, Ian
    Abdel-Wahab, May
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (03) : 403 - 408